The grants to four scientists at Columbia University Vagelos College of Physicians and Surgeons support unconventional approaches to major challenges in biomedical and behavioral research.
Physician-scientist Juanma Schvartzman is a firm believer that his curiosity-driven research on cell metabolism and its influence on cell identity will offer clues for better cancer treatments.
A new study finds that many of our genes, if disabled by a mutation, have a surprising ability to turn on backup genes to compensate for lost functions.
Columbia's Maja Bergman discuss the types of challenges domestic violence survivors face, effective therapies for those who experience domestic abuse, and warning signs that someone may be an abuser.
A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
The EQUIP Center for Learning Health System Science will support researchers working to improve patient safety, particularly among groups that experience persistent health care disparities.
Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Understanding what drives gut stem cells to work nonstop may reveal how idle stem cells elsewhere can be revved up to repair hearts, lungs, and brains. But are scientists studying the right cells?
A novel omega-3 injectable emulsion reduces brain damage in newborn rodents experiencing lack of oxygen at delivery, a major cause of disability in human infants and children.
Researchers at Columbia University College of Dental Medicine have engineered exosomes to carry CRISPR, significantly enhancing the delivery of genome editing components to specific cells and tissues.